Your browser doesn't support javascript.
loading
Antibodies Elicited by Multiple Envelope Glycoprotein Immunogens in Primates Neutralize Primary Human Immunodeficiency Viruses (HIV-1) Sensitized by CD4-Mimetic Compounds.
Madani, Navid; Princiotto, Amy M; Easterhoff, David; Bradley, Todd; Luo, Kan; Williams, Wilton B; Liao, Hua-Xin; Moody, M Anthony; Phad, Ganesh E; Vázquez Bernat, Néstor; Melillo, Bruno; Santra, Sampa; Smith, Amos B; Karlsson Hedestam, Gunilla B; Haynes, Barton; Sodroski, Joseph.
Afiliación
  • Madani N; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Princiotto AM; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts.
  • Easterhoff D; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Bradley T; Duke Human Vaccine Institute, Department of Medicine, and Department of Immunology, Duke University Medical Center, Durham, NC, USA.
  • Luo K; Duke Human Vaccine Institute, Department of Medicine, and Department of Immunology, Duke University Medical Center, Durham, NC, USA.
  • Williams WB; Duke Human Vaccine Institute, Department of Medicine, and Department of Immunology, Duke University Medical Center, Durham, NC, USA.
  • Liao HX; Duke Human Vaccine Institute, Department of Medicine, and Department of Immunology, Duke University Medical Center, Durham, NC, USA.
  • Moody MA; Duke Human Vaccine Institute, Department of Medicine, and Department of Immunology, Duke University Medical Center, Durham, NC, USA.
  • Phad GE; Duke Human Vaccine Institute, Department of Medicine, and Department of Immunology, Duke University Medical Center, Durham, NC, USA.
  • Vázquez Bernat N; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Melillo B; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Santra S; Department of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Smith AB; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Karlsson Hedestam GB; Department of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Haynes B; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Sodroski J; Duke Human Vaccine Institute, Department of Medicine, and Department of Immunology, Duke University Medical Center, Durham, NC, USA.
J Virol ; 90(10): 5031-5046, 2016 05 15.
Article en En | MEDLINE | ID: mdl-26962221
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Anticuerpos Anti-VIH / Antígenos CD4 / VIH-1 / Fármacos Anti-VIH / Productos del Gen env del Virus de la Inmunodeficiencia Humana / Anticuerpos Neutralizantes Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Virol Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Anticuerpos Anti-VIH / Antígenos CD4 / VIH-1 / Fármacos Anti-VIH / Productos del Gen env del Virus de la Inmunodeficiencia Humana / Anticuerpos Neutralizantes Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Virol Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos